The article examines how public sector involvement in agricultural biotechnology research affects welfare. It looks at a model where private and public firms compete in a patent race with research spillovers. The results show that public firms can improve research efficiency and reduce market distortions, but may face challenges in balancing investment levels. Public firms invest more when spillovers and market distortions are high, but may struggle to achieve optimal outcomes due to cost smoothing issues.